EG-501

N/A

Report date: 2025/11/03 15:21:15
NME

Base Information

Drug NameEG-501
Drug Alias NameEG-501
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsCognition DisordersLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEvergreen Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEvergreen Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCognition DisordersLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A